Dr. Leonardo Forero, MD

Hematology & Oncology Amarillo, TX Male
NPI: 1700847464
Total Payments
$41,835
2024 Payments
$638.21
Companies
33
Transactions
137
Medicare Patients
15,200
Medicare Billing
$7.8M

Payment Breakdown by Category

Other$20,050 (47.9%)
Research$11,171 (26.7%)
Food & Beverage$4,072 (9.7%)
Consulting$3,100 (7.4%)
Travel$3,067 (7.3%)
Education$375.83 (0.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $20,050 6 47.9%
Unspecified $11,171 2 26.7%
Food and Beverage $4,072 100 9.7%
Consulting Fee $3,100 6 7.4%
Travel and Lodging $3,067 13 7.3%
Education $375.83 10 0.9%

Payments by Type

General
$30,665
135 transactions
Research
$11,171
2 transactions

Top Paying Companies

Company Total Records Latest Year
E.R. Squibb & Sons, L.L.C. $20,501 47 $0 (2024)
Celgene Corporation $11,202 4 $0 (2018)
Merck Sharp & Dohme Corporation $6,046 13 $0 (2019)
Foundation Medicine, Inc. $1,355 4 $0 (2019)
Astellas Pharma US Inc $402.18 6 $0 (2023)
PFIZER INC. $334.69 8 $0 (2024)
Novartis Pharmaceuticals Corporation $210.52 10 $0 (2021)
Seattle Genetics, Inc. $208.84 2 $0 (2019)
Sirtex Medical Inc $188.56 2 $0 (2019)
Janssen Scientific Affairs, LLC $179.09 4 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2024 $638.21 7 PFIZER INC. ($239.65)
2023 $273.91 6 Astellas Pharma US Inc ($215.45)
2022 $654.79 19 E.R. Squibb & Sons, L.L.C. ($423.72)
2021 $178.63 6 E.R. Squibb & Sons, L.L.C. ($100.00)
2020 $33.94 2 Janssen Scientific Affairs, LLC ($21.89)
2019 $9,456 41 Merck Sharp & Dohme Corporation ($5,700)
2018 $7,301 29 E.R. Squibb & Sons, L.L.C. ($5,055)
2017 $23,299 27 E.R. Squibb & Sons, L.L.C. ($12,108)

All Payment Transactions

137 individual payment records from CMS Open Payments — Page 1 of 6

Date Company Product Nature Form Amount Type
11/07/2024 Janssen Biotech, Inc. ERLEADA (Drug), AKEEGA Food and Beverage In-kind items and services $121.84 General
Category: Oncology
10/17/2024 PFIZER INC. ADCETRIS (Biological) Food and Beverage In-kind items and services $114.65 General
Category: Oncology
09/10/2024 AstraZeneca Pharmaceuticals LP — Food and Beverage In-kind items and services $125.00 General
09/04/2024 E.R. Squibb & Sons, L.L.C. — Food and Beverage Cash or cash equivalent $38.20 General
08/15/2024 Daiichi Sankyo Inc. Enhertu (Drug) Food and Beverage In-kind items and services $90.00 General
Category: ONCOLOGY
04/11/2024 PFIZER INC. PADCEV (Biological) Food and Beverage In-kind items and services $125.00 General
Category: Oncology
02/20/2024 PUMA BIOTECHNOLOGY, INC. — Food and Beverage In-kind items and services $23.52 General
08/02/2023 ImmunoGen, Inc. Elahere (Biological) Food and Beverage In-kind items and services $17.38 General
Category: Oncology
06/29/2023 Astellas Pharma US Inc — Education In-kind items and services $99.99 General
06/26/2023 Astellas Pharma US Inc — Education In-kind items and services $99.00 General
06/13/2023 Abbott Laboratories PROCLAIM (Device) Food and Beverage In-kind items and services $25.08 General
Category: Neuromodulation
06/09/2023 Astellas Pharma US Inc Xtandi (Drug) Food and Beverage In-kind items and services $16.46 General
Category: Oncology
02/15/2023 AstraZeneca Pharmaceuticals LP TAGRISSO (Drug) Food and Beverage In-kind items and services $16.00 General
Category: Oncology
12/15/2022 E.R. Squibb & Sons, L.L.C. — Food and Beverage Cash or cash equivalent $24.39 General
12/15/2022 E.R. Squibb & Sons, L.L.C. — Food and Beverage Cash or cash equivalent $8.07 General
12/15/2022 E.R. Squibb & Sons, L.L.C. — Food and Beverage Cash or cash equivalent $7.06 General
12/14/2022 Amgen Inc. XGEVA (Biological) Food and Beverage In-kind items and services $16.48 General
Category: Oncology
11/30/2022 Tactile Systems Technology Inc Flexitouch Plus (Device), entre Food and Beverage In-kind items and services $12.98 General
Category: PNEUMATIC COMPRESSOR
11/10/2022 GENZYME CORPORATION SARCLISA (Biological) Food and Beverage In-kind items and services $17.80 General
Category: Oncology
09/20/2022 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $2.11 General
Category: Oncology
09/14/2022 Karyopharm Therapeutics Inc. XPOVIO (Drug) Food and Beverage In-kind items and services $23.00 General
Category: Oncology
08/03/2022 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $5.98 General
Category: Oncology
07/19/2022 Karyopharm Therapeutics Inc. XPOVIO (Drug) Food and Beverage In-kind items and services $13.39 General
Category: Oncology
06/30/2022 E.R. Squibb & Sons, L.L.C. — Food and Beverage Cash or cash equivalent $29.68 General
06/07/2022 Seagen Inc. TUKYSA (Drug) Food and Beverage In-kind items and services $110.42 General
Category: Oncology
123…6»

Research Studies & Clinical Trials

Study Name Company Amount Records
ABI-007-NSCL-005 Celgene Corporation $10,811 1
ABI-007-NSCL-005 - Safety and Efficacy of nab-paclitaxel (Abraxane) in Combination with Carboplatin as First Line Treatment in Elderly Subjects with Advance Non-Small Cell Lung Cancer (NSCLC): A Phase IV, Randomized, Op Celgene Corporation $360.00 1

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 71 3,557 205,722 $6.7M $1.2M
2022 73 3,689 220,846 $7.9M $1.6M
2021 79 4,375 347,553 $12.8M $2.7M
2020 65 3,579 276,360 $10.1M $2.3M
Total Patients
15,200
Total Services
1,050,481
Medicare Billing
$7.8M
Procedure Codes
288

All Medicare Procedures & Services

288 procedure records from CMS Medicare Utilization — Page 1 of 12

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
J9271 Injection, pembrolizumab, 1 mg Office 2023 23 11,700 $1.6M $505,589 31.6%
J0897 Injection, denosumab, 1 mg Office 2023 78 7,440 $489,960 $136,062 27.8%
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj Office 2023 11 3,060 $387,360 $115,834 29.9%
J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg Office 2023 12 2,730 $636,060 $90,287 14.2%
96413 Administration of chemotherapy into vein, 1 hour or less Office 2023 146 463 $327,341 $45,128 13.8%
J1439 Injection, ferric carboxymaltose, 1 mg Office 2023 52 48,000 $192,000 $41,197 21.5%
J1454 Injection, fosnetupitant 235 mg and palonosetron 0.25 mg Office 2023 41 94 $161,868 $32,720 20.2%
Q5119 Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg Office 2023 11 1,440 $260,640 $29,989 11.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 86 319 $117,392 $28,713 24.5%
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) Office 2023 30 10,150 $203,000 $24,070 11.9%
78815 Nuclear medicine study from skull base to mid-thigh with ct scan Office 2023 20 21 $100,842 $23,293 23.1%
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less Office 2023 187 334 $104,542 $15,897 15.2%
74177 Ct scan of abdomen and pelvis with contrast Office 2023 65 73 $77,891 $12,095 15.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 147 188 $47,000 $11,032 23.5%
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Office 2023 33 26,520 $132,600 $10,622 8.0%
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less Office 2023 126 441 $69,237 $9,593 13.9%
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l Office 2023 20 67 $33,500 $8,218 24.5%
96417 Administration of additional new drug or substance into vein, 1 hour or less Office 2023 59 172 $59,168 $8,203 13.9%
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle Office 2023 25 135 $28,485 $7,350 25.8%
Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram Office 2023 25 23,520 $47,040 $6,040 12.8%
71260 Ct scan of chest with contrast Office 2023 100 111 $91,131 $5,889 6.5%
96415 Administration of chemotherapy into vein, each additional hour Office 2023 61 242 $38,962 $5,128 13.2%
Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units Office 2023 12 823 $23,044 $4,995 21.7%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 27 33 $16,368 $4,375 26.7%
96375 Injection of additional new drug or substance into vein Office 2023 93 369 $39,852 $4,275 10.7%
123…12»

About Dr. Leonardo Forero, MD

Dr. Leonardo Forero, MD is a Hematology & Oncology healthcare provider based in Amarillo, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700847464.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Leonardo Forero, MD has received a total of $41,835 in payments from pharmaceutical and medical device companies, with $638.21 received in 2024. These payments were reported across 137 transactions from 33 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($20,050).

As a Medicare-enrolled provider, Forero has provided services to 15,200 Medicare beneficiaries, totaling 1,050,481 services with total Medicare billing of $7.8M. Data is available for 4 years (2020–2023), covering 288 distinct procedure/service records.

Practice Information

  • Specialty Hematology & Oncology
  • Other Specialties Medical Oncology
  • Location Amarillo, TX
  • Active Since 03/31/2006
  • Last Updated 12/20/2021
  • Taxonomy Code 207RH0003X
  • Entity Type Individual
  • NPI Number 1700847464

Products in Payments

  • OPDIVO (Biological) $19,821
  • Abraxane (Drug) $11,171
  • KEYTRUDA (Biological) $6,046
  • FOUNDATIONACT (Device) $1,329
  • ADCETRIS (Biological) $323.49
  • SIR-Spheres Microspheres (Device) $188.56
  • PADCEV (Biological) $125.00
  • ERLEADA (Drug) $121.84
  • XTANDI (Drug) $115.64
  • TUKYSA (Drug) $110.42
  • KISQALI (Drug) $102.72
  • Enhertu (Drug) $90.00
  • Erleada (Drug) $80.49
  • DARZALEX (Drug) $76.71
  • Oncology (Device) $76.01
  • Stivarga (Drug) $73.28
  • VERZENIO (Drug) $72.19
  • PROCLAIM (Device) $47.53
  • LIBTAYO (Drug) $44.68
  • MEKINIST (Drug) $44.03

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Hematology & Oncology Doctors in Amarillo

Dr. Andrew Mak, M.d, M.D

Hematology & Oncology — Payments: $4,481

Hematology & Oncology $4,481

Paul Zorsky, M.d, M.D

Hematology & Oncology — Payments: $2,440

Hematology & Oncology $2,440

Javed Shinwari, M.d, M.D

Hematology & Oncology — Payments: $2,382

Hematology & Oncology $2,382

Dr. Shrestha Patel, D.o, D.O

Hematology & Oncology — Payments: $1,409

Hematology & Oncology $1,409

Dr. Milan Patel, Md, MD

Hematology & Oncology — Payments: $1,233

Hematology & Oncology $1,233

Dr. William Esler, Md, MD

Hematology & Oncology — Payments: $43.59

Hematology & Oncology $43.59